CLINICAL_TRIALS
trial_result
· 2022-12-16
Clinical Trial Update: A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease [Phase 2]
Summary
Phase 2 trial update for YPEG-rhEPO in patients with anemia due to chronic kidney disease has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Renal Anemia of Chronic Kidney Disease | Phase 2 | Status: COMPLETED